Home > Boards > US OTC > Delisted > Nuvectra Corp. (fka NVTRQ)

But no reason why it won’t go through.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
joseytheoutlawwales Member Profile
 
Followed By 102
Posts 6,933
Boards Moderated 1
Alias Born 12/17/09
160x600 placeholder
Europe's Most Valuable Tech Company Can Help the Chip Shortage--Heard on the Street
Good news for anyone looking for a new car: The microchip industry is mustering faster than expected to solve today's crippling shortages.
Pfizer On Pace for Longest Winning Streak In Over 30 Years -- Data Talk
FDA Finds Poor Conditions at Contractor's Plant for Making J&J's Covid-19 Vaccine
Existing Home Sales Seen Down, New Home Sales Expected to Rise -- Data Week Ahead
Stocks Open Lower Amid Concerns About Covid-19 Infection Rate
Uber to Launch Food Delivery Platform in Germany
Form 8.3 -Willis Towers Watson Plc
Brazilian Real Is Biggest Threat to Heineken's Revenue -- Currency Comment
NatWest Group Says Making Good Progress on Its Strategy
Stocks Open Lower Amid Concerns Around Covid-19 Infection Rate
Top Company News of the Day
Pfizer Identifies Fake Covid-19 Shots Abroad as Criminals Exploit Vaccine Demand
Researchers Uncover Advertising Scam Targeting Streaming-TV Apps
The Job Market Is Tighter Than You Think -- Capital Account
NextEra Energy 1Q Adjusted Earnings Beat Wall Street Views
Verizon Profit, Revenue Increase in 1Q
ASML Raises 2021 Outlook as Chip Shortage Boosts Demand -- Update
Ericsson 1Q Earnings Rise on Continued 5G Traction -- Earnings Review
Johnson & Johnson Gets U.S., Europe Approval for Veritas Vision System
TE Connectivity Expects 3Q Sales to Rise
Anthem Raises Full-Year Earnings Outlook
Anthem 1Q Revenue, Profit Grow as Membership Expands
TE Connectivity Swings to 2Q Profit
Correction to Expat Americans Covid-19 Vaccination Shots on April 17
Iron Ore Price Rally Blunts China's Trade Pressure
joseytheoutlawwales   Thursday, 04/23/20 04:13:20 PM
Re: Shackster13795 post# 1486
Post # of 1509 
But no reason why it won’t go through. Judge bought and paid for clearly, as this deal f—ks over providers, patients, investors, everyone but cirtec and prior NVTR management.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences